Improvements to the Vulva, Vestibule, Urethral Meatus, and Vagina in Women Treated With Ospemifene for Moderate to Severe Dyspareunia: A Prospective Vulvoscopic Pilot Study

INTRODUCTION: Ospemifene, an oral selective estrogen receptor modulator approved for the treatment of mild to moderate dyspareunia from menopause, has been shown to moderate sexual pain and vaginal epithelial cell characteristics. However, no prospective vulvoscopic studies have been performed. AIM:...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, Sue W., Winter, Ashley G., Goldstein, Irwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960031/
https://www.ncbi.nlm.nih.gov/pubmed/29678557
http://dx.doi.org/10.1016/j.esxm.2018.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960031/
https://www.ncbi.nlm.nih.gov/pubmed/29678557
http://dx.doi.org/10.1016/j.esxm.2018.03.002

Ejemplares similares